Philips Publishes Q3 2026 Results Webcast Transcript

By Public Technologies15:13 (UTC), 4 November 2026 Updated

Philips reaffirmed its 2026 outlook at its November 3 Q3 results call, attended by CEO Roy Jakobs and CFO Charlotte Hanneman.
Full-year comparable sales growth remains projected at 3%-4.5%; adjusted EBITA margin guidance stays at 13.5%-14%.
Quarterly equipment order intake rose 8%; adjusted EBITA margin increased 70 basis points to 13%.
A Respironics agreement in principle with the US Justice Department triggered a €288 million provision, with payment expected in Q1 2027.
Management raised Personal Health’s full-year sales growth outlook to the lower end of high single digits, citing broad-based demand and market-share gains.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royal Philips NV published the original content used to generate this news brief on November 04, 2026, and is solely responsible for the information contained therein.